Skip to main content
Clinical Trials/NCT00929747
NCT00929747
Withdrawn
Phase 4

Comparison of Corneal Aberrations and Visual Outcomes in AcrySof IQ Toric Patients Versus LRI Patients

Alcon Research1 site in 1 countryJune 2009
ConditionsCataracts

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Cataracts
Sponsor
Alcon Research
Locations
1
Primary Endpoint
Corneal aberration
Status
Withdrawn
Last Updated
14 years ago

Overview

Brief Summary

A prospective evaluation of postoperative corneal aberrations and visual parameters in patients assigned to either an AcrySof IQ Toric intraocular lens (IOL) group or a group implanted with a SN60WF IOL and having concomitant limbal relaxing incision.

Registry
clinicaltrials.gov
Start Date
June 2009
End Date
October 2009
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • operable cataracts
  • good ocular health
  • 0.5 D to 2.0 D of corneal astigmatism

Exclusion Criteria

  • \> 2.0 D astigmatism
  • irregular astigmatism
  • prior or ongoing corneal disease or scarring
  • history of ocular disease

Outcomes

Primary Outcomes

Corneal aberration

Time Frame: 3 months

Secondary Outcomes

  • Visual acuity(3 months)

Study Sites (1)

Loading locations...

Similar Trials